Gestational diabetes & diabetes in pregnancy

Maternal Diabetes, Fetal Growth, and Stillbirth Risk: A Population-Wide Retrospective Cohort Study From Victoria, Australia

Diabetes CarePublished Population-based retrospective cohort study

Authors' conclusion

In our cohort, gestational diabetes was associated with a lower stillbirth risk compared with no diabetes, which potentially can be explained by increased monitoring and earlier iatrogenic delivery. Preexisting diabetes was associated with a higher overall risk of stillbirth, with macrosomic fetuses in the >97th centile representing a particularly high-risk group requiring close monitoring.

Study context

Population
All singleton births in Victoria, Australia, 2009–2020; 100,856 pregnancies (11.7%) complicated by diabetes
Participants
860,042 births
Exposure
Diabetes in pregnancy vs no diabetes
Outcome
Stillbirth risk
Methodological detailspopulation-wide, linked perinatal and diabetes data
  • Population-wide
  • Linked perinatal and diabetes data

Main finding

As reported in the abstract

Stillbirth
Each group vs no diabetesRelative risk (95% CI)
GDM diet-controlled
0.75(0.64–0.89)
GDM insulin-controlled
0.37(0.25–0.50)
Preexisting diabetestrend persisted across all gestational ages and birth weights
2.68(2.01–3.56)

Observational data: associations, not effects.

Further findings

OutcomeRR (95% CI)
Stillbirth in infants >97th centileT1Dvs No diabetes3.96 (1.23–12.76)
Stillbirth in infants >97th centileT2Dvs No diabetes4.02 (1.71–9.47)
OutcomeNo diabetes
Gestation at birthmedian 39.4 weeks
Iatrogenic births44%
  • Gestation at birth: Diabetes in pregnancy median 38.7 weeks
  • Iatrogenic births: Diabetes in pregnancy 65%

Original publication

Maternal Diabetes, Fetal Growth, and Stillbirth Risk: A Population-Wide Retrospective Cohort Study From Victoria, Australia. Diabetes Care. Published 3 September 2025. doi:10.2337/dc25-0833

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.